Clinical Trial: A Randomized Controlled Study Comparing the Efficacy and Safety of R2-CHOP versus R-CHOP as First-Line Treatment for Elderly Patients with HIV-Associated Diffuse Large B-Cell Lymphoma (China)

China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Randomized Controlled Study Comparing the Efficacy and Safety of R2-CHOP versus R-CHOP as First-Line Treatment for Elderly Patients with HIV-Associated Diffuse Large B-Cell Lymphoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132819

Registration Time: 2026/09/18

Type: Interventional study

Primary Sponsor: Southern Medical University Southern Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343726

Published by HT Digital Content Services with permission from Health Daily Digest....